APA (7th ed.) Citation

CD, C., A, M., B, G., N, J., S, F., NS, M., . . . TLS, B. (2023). Longitudinal head-to-head comparison of 11C-PiB and 18F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer's disease. European journal of nuclear medicine and molecular imaging, 50(9), 2669. https://doi.org/10.1007/s00259-023-06209-0

Chicago Style (17th ed.) Citation

CD, Chen, et al. "Longitudinal Head-to-head Comparison of 11C-PiB and 18F-florbetapir PET in a Phase 2/3 Clinical Trial of Anti-amyloid-β Monoclonal Antibodies in Dominantly Inherited Alzheimer's Disease." European Journal of Nuclear Medicine and Molecular Imaging 50, no. 9 (2023): 2669. https://doi.org/10.1007/s00259-023-06209-0.

MLA (9th ed.) Citation

CD, Chen, et al. "Longitudinal Head-to-head Comparison of 11C-PiB and 18F-florbetapir PET in a Phase 2/3 Clinical Trial of Anti-amyloid-β Monoclonal Antibodies in Dominantly Inherited Alzheimer's Disease." European Journal of Nuclear Medicine and Molecular Imaging, vol. 50, no. 9, 2023, p. 2669, https://doi.org/10.1007/s00259-023-06209-0.